ProMIS Neurosciences Inc.
ProMIS Neurosciences is a clinical-stage biotechnology company focused on discovering and developing therapeutic antibodies that selectively target toxic oligomers associated with neurodegenerative and other misfolded protein diseases. Their proprietary EpiSelect™ platform identifies Disease Specific Epitopes (DSEs) on misfolded proteins, enabling the creation of highly selective antibodies. They are developing treatments for diseases like Alzheimer's, ALS, and Parkinson's disease, positioning themselves as innovators in precision medicine for neurodegenerative disorders.
Official Registry
AI Quality Analysis
Trust Score Breakdown
Quick Links
Website Highlights
🌟 Similar Trusted Businesses
Context Therapeutics Inc.
Context Therapeutics is dedicated to advancing the treatment of solid tumors through the development of next-generation T cell engaging (TCE) bispecific antibody therapies. Their innovative pipeline features clinical-stage bispecific therapeutics designed to harness the immune system for targeted cancer eradication. The company focuses on innovative immunotherapeutic solutions, transforming cancer care and improving outcomes for patients.
AGENUS INC
Agenus is a biotechnology company focused on developing and commercializing immuno-oncology therapies. Their key products include botensilimab and balstilimab, which are in clinical trials for various cancers. The company is positioned as an innovator in the development of next-generation immunotherapies.
Evaxion A/S
Evaxion utilizes its AI-Immunology™ platform to challenge and improve standardized treatments. In oncology, they create personalized therapies, tailoring treatment to the individual. For infectious diseases, they design next-generation vaccines to address unmet medical needs. Their AI platform accelerates vaccine target discovery, design, and development.